Evaluation of FGFR3 As a Therapeutic Target in Head and Neck Squamous Cell Carcinoma
Targeted oncology(2016)
摘要
Although head and neck squamous cell carcinoma (HNSCC) is the sixth most common tumour entity worldwide, it remains a clinical challenge. Large-scale explorative genomic projects have identified several genes as potential targets for therapy, including fibroblast growth factor receptor 3 (FGFR3).
更多查看译文
关键词
HSC3 Cell,FGFR3 Mutation,FGFR3 Expression,Human Papilloma Virus Status,Thiazolyl Blue Tetrazolium Bromide
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要